Condensed Balance Sheet (Unaudited)	Mar. 31, 2021 USD ($)
ASSETS
Deferred offering costs	$ 137,363
TOTAL ASSETS	137,363
LIABILITIES AND SHAREHOLDERS’ EQUITY
Accrued offering costs	117,363
Total Current Liabilities	117,363
Commitments
Shareholders’ Equity
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no shares issued and outstanding
Class B ordinary shares, $0.000 par value; 50,000,000 shares authorized; 6,325,000 shares issued and outstanding	633	[1]
Additional paid-in capital	24,367
Accumulated deficit	(5,000)
Total Shareholders’ Deficit	20,000
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 137,363

[1] Includes up to 825,000 Class B ordinary shares that are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised in full or in part. On April 6, 2021, the Company effected a share capitalization of 862,500 shares, which resulted in 7,187,500 founder shares issued and outstanding as of the date thereof. On April 29, 2021, our sponsor surrendered 862,500 founder shares and, as a result, there are 6,325,000 founder shares issued and outstanding. All share and per share amounts have been retroactively restated to reflect the share capitalization (see Note 5). As further discussed in Note 8, the Company completed its initial public offering on May 4, 2021.